158 related articles for article (PubMed ID: 36577160)
21. Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.
Chartrand S; Lee JS; Swigris JJ; Stanchev L; Fischer A
Lung; 2019 Dec; 197(6):709-713. PubMed ID: 31583453
[TBL] [Abstract][Full Text] [Related]
22. Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review.
Ge Y; Peng Q; Zhang S; Zhou H; Lu X; Wang G
Clin Rheumatol; 2015 Jan; 34(1):99-105. PubMed ID: 25367345
[TBL] [Abstract][Full Text] [Related]
23. Interstitial Lung Disease in Dermatomyositis Without Myositis-Specific and Myositis-Associated Autoantibodies: Study of a Series of 72 Patients From a Single Cohort.
Chen F; Wang J; Zhang P; Zuo Y; Ye L; Wang G; Shu X
Front Immunol; 2022; 13():879266. PubMed ID: 35603153
[TBL] [Abstract][Full Text] [Related]
24. Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study.
Liang J; Cao H; Ke Y; Sun C; Chen W; Lin J
Front Med (Lausanne); 2020; 7():12. PubMed ID: 32083087
[No Abstract] [Full Text] [Related]
25. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
26. Elevated level of serum human epididymis protein 4 (HE4) predicts disease severity and mortality in COVID-19 pneumonia.
Sütő R; Pócsi M; Szabó Z; Fejes Z; Ivády G; Kerekes G; Fagyas M; Nagy A; Szentkereszty Z; Kappelmayer J; Nagy B
BMC Pulm Med; 2023 Dec; 23(1):512. PubMed ID: 38104063
[TBL] [Abstract][Full Text] [Related]
27. CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease.
Wang K; Zhao J; Chen Z; Li T; Tan X; Zheng Y; Gu L; Guo L; Sun F; Wang H; Li J; Wang X; Riemekasten G; Ye S
Rheumatology (Oxford); 2019 Mar; 58(3):511-521. PubMed ID: 30508148
[TBL] [Abstract][Full Text] [Related]
28. Fever in the initial stage of IIM patients: an early clinical warning sign for AE-ILD.
Liu T; Chen H; Shi Y; Xu W; Yuan F
Adv Rheumatol; 2023 Jul; 63(1):31. PubMed ID: 37443073
[TBL] [Abstract][Full Text] [Related]
29. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
[TBL] [Abstract][Full Text] [Related]
30. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
[TBL] [Abstract][Full Text] [Related]
31. The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study.
Zhou P; Shen Q; Zhou S; Ouyang X; Guo T; Song M; Guo W; Zhang Y; Peng H
Sci Rep; 2023 Mar; 13(1):3863. PubMed ID: 36890164
[TBL] [Abstract][Full Text] [Related]
32. The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review.
Teel A; Lu J; Park J; Singh N; Basharat P
Semin Arthritis Rheum; 2022 Dec; 57():152088. PubMed ID: 36116345
[TBL] [Abstract][Full Text] [Related]
33. Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications.
Yeo J; Yoon SH; Kim JY; Lee JS; Lee EY; Goo JM; Pourzand L; Goldin JG; Kim GJ; Ha YJ
Rheumatology (Oxford); 2023 Nov; 62(11):3690-3699. PubMed ID: 36929924
[TBL] [Abstract][Full Text] [Related]
34. Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies: results from a cohort from China.
Wen L; Chen X; Cheng Q; Nie L; Xu J; Yan T; Zhang X; Yang H; Sun W; Liu L; Xue J; Du Y
Clin Rheumatol; 2022 Nov; 41(11):3419-3427. PubMed ID: 35859245
[TBL] [Abstract][Full Text] [Related]
35. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
36. Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis.
Barba T; Fort R; Cottin V; Provencher S; Durieu I; Jardel S; Hot A; Reynaud Q; Lega JC
Autoimmun Rev; 2019 Feb; 18(2):113-122. PubMed ID: 30572131
[TBL] [Abstract][Full Text] [Related]
37. Myositis Antibodies and Interstitial Lung Disease.
Basuita M; Fidler LM
J Appl Lab Med; 2022 Jan; 7(1):240-258. PubMed ID: 34996093
[TBL] [Abstract][Full Text] [Related]
38. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
Bai Z; Shen G; Dong L
Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
[TBL] [Abstract][Full Text] [Related]
39. Comparison of pulmonary and small airways function between idiopathic inflammatory myopathies patients with and without interstitial lung disease.
Panagopoulos PK; Georgakopoulou VE; Pezoulas VC; Malagari K; Fotiadis DI; Goules AV; Vassilakopoulos T; Tzioufas AG
Clin Exp Rheumatol; 2024 Feb; 42(2):337-343. PubMed ID: 37382448
[TBL] [Abstract][Full Text] [Related]
40. A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia.
Chartrand S; Swigris JJ; Peykova L; Chung J; Fischer A
J Rheumatol; 2016 May; 43(5):887-92. PubMed ID: 26932342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
